Form 4: Eton Pharmaceuticals Director Norbert G. Riedel Exercises Stock Options
SEC Form 4 Filing
Director Norbert G. Riedel exercised employee stock options to acquire common stock in Eton Pharmaceuticals on January 3, 2025.
Summary
- On January 3, 2025, Norbert G. Riedel, a director of Eton Pharmaceuticals, Inc., exercised employee stock options.
- These transactions involved the acquisition of common stock at prices of $3.58, $3.78, and $3.47 per share.
- The exercises resulted in the acquisition of 27,400 shares at $3.58, 50,000 shares at $3.78, and 25,000 shares at $3.47.
- Following these transactions, Riedel directly owns 162,145 shares of Eton Pharmaceuticals common stock.
- The options exercised had original grant dates in 2021, 2023 and 2024 and expire in 2030, 2032 and 2033 respectively.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard Form 4 filing indicating stock option exercises. It doesn't inherently suggest positive or negative implications for the company's performance.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership structure.
Key Dates
| Date | Description |
|---|---|
| 03/12/2021 | Grant date of one of the employee stock options. |
| 02/07/2023 | Grant date of one of the employee stock options. |
| 02/20/2024 | Grant date of one of the employee stock options. |
| 01/03/2025 | Date of stock option exercise and stock acquisition. |
| 01/06/2025 | Date of Form 4 filing. |
| 03/12/2030 | Expiration date of one of the employee stock options. |
| 02/06/2032 | Expiration date of one of the employee stock options. |
| 02/19/2033 | Expiration date of one of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.